NCT02213757View on ClinicalTrials.gov

Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)

PHASE4TerminatedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Microscopic Hematuria

Interventions

DRUG

Premarin vaginal estrogen cream

DRUG

Placebo vaginal cream

Inactive vaginal cream manufactured to mimic Premarin vaginal cream

Trial Locations (1)

20001

MedStar Washington Hospital Center, Washington D.C.

Sponsors

Lead Sponsor

Medstar Health Research Institute

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Medstar Health Research Institute

OTHER